NCT02415309

Brief Summary

Lumbar medial branch blocks are commonly used as a diagnostic tool for facet-mediated chronic low back pain. This interventional pain procedure often occurs in the fluoroscopy suite. During this procedure, a physician inserts the needles to deliver local anesthetics such as lidocaine or bupivacaine to the nerves which innervate the lumbar facet joint. Many patients experience anxiety before and during the lumbar medial branch block procedure and require intravenous midazolam or fentanyl for sedation. Intravenous or conscious sedation requires one-to-one nursing care, monitoring, and recovery. In order to minimize the costs and time requirements of intravenous sedation, a suitable oral medication which is readily available and non-controlled would be ideal. Several randomized double-blinded, controlled trials have investigated the anxiolytic effects of melatonin before a surgery; however no studies to date have studied the anxiolytic effects of melatonin before less invasive interventional pain procedures. This study is designed to evaluate the efficacy of melatonin for reducing anxiety in patients undergoing a lumbar medial branch block procedure. The study is a randomized, double-blinded, placebo-controlled trial with 40 patients in each group: 2 mg melatonin, 10 mg melatonin and placebo. The primary outcome is anxiety reduction in patients before undergoing the procedure. The primary outcome is measured by visual numerical rating scale for anxiety and the Amsterdam Preoperative Anxiety and Information Scale. Based on the results of previous studies, the investigators hypothesize that melatonin may reduce anxiety in patients undergoing the procedure and be a suitable alternative to intravenous sedation in the pain clinic for patients undergoing lumbar medial branch blocks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for phase_3 anxiety

Timeline
Completed

Started Jul 2016

Longer than P75 for phase_3 anxiety

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 14, 2015

Completed
1.2 years until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

5.8 years

First QC Date

April 6, 2015

Last Update Submit

May 11, 2024

Conditions

Keywords

MelatoninLumbar medial branch block (LMBB)AnxietyInterventional PainPain Procedure

Outcome Measures

Primary Outcomes (1)

  • Change in anxiety level scores as assessed by the data collection sheet given to patients at all three time points (listed below)

    Comparing melatonin and placebo to see if differing levels of melatonin helps prevent or alleviate anxiety in service members undergoing an interventional pain procedure. For patients participating in the LMBB, anxiety level scores will be compared among the three time-points. Primary analysis will compare the two treatment groups versus placebo. The goal of this study is to demonstrate whether melatonin has anxiolytic effects preoperatively.

    Anxiety levels will be assessed at check-in time (90 minutes before procedure), immediately before procedure, and 90 minutes post-operatively.

Study Arms (3)

2 mg Melatonin

ACTIVE COMPARATOR

To remain within the doses used for anxiolytic effects in past studies, we plan to study the effects of 2mg melatonin.

Drug: 2 mg Melatonin

10 mg Melatonin

ACTIVE COMPARATOR

To remain within the doses used for anxiolytic effects in past studies, we plan to study the effects of 10mg melatonin.

Drug: 10mg Melatonin

Sugar Pill

PLACEBO COMPARATOR

To remain within the doses used for anxiolytic effects in past studies, we plan to study the effects of two different levels of melatonin versus placebo as premedication in patients undergoing a lumbar medial branch block (LMBB) procedure.

Other: Placebo

Interventions

40 patients will randomly receive 2 mg melatonin

Also known as: N-acetyl-5-methoxytripatamin
2 mg Melatonin

40 patients will randomly receive 10 mg melatonin

Also known as: N-acetyl-5-methoxytripatamin
10 mg Melatonin
PlaceboOTHER

40 patients will randomly receive a placebo/sugar pill

Also known as: Sugar Pill
Sugar Pill

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • undergoing LMBB procedure
  • both genders between the ages of 18-50

You may not qualify if:

  • patients with active pregnancy (due to ionizing radiation)
  • liver disease
  • contraindications to LMBB procedure
  • patient refusal
  • localized or systemic infection
  • low platelet count
  • fibromyalgia
  • use of sedative medications
  • failure to comply with procedures
  • investigator's determination that the assigned treatment is ineffective or unsafe
  • appearance of unacceptable side effects in the subject

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Pain Medicine Center

San Diego, California, 92134, United States

Location

Naval Medical Center Portsmouth

Portsmouth, Virginia, United States

Location

Related Publications (24)

  • Wheeler AH. Diagnosis and management of low back pain and sciatica. Am Fam Physician. 1995 Oct;52(5):1333-41, 1347-8.

    PMID: 7572557BACKGROUND
  • Slipman CW, Derby R, Simeone FA, et al. Slipman: Interventional Spine: An Algorithmic Approach, 1st ed. Elsevier Inc 2008.

    BACKGROUND
  • Wurtman R. Physiology and clinical use of melatonin. www.uptodate.com. Accessed 2/8/15.

    BACKGROUND
  • Cramer H, Rudolph J, Consbruch U, Kendel K. On the effects of melatonin on sleep and behavior in man. Adv Biochem Psychopharmacol. 1974;11(0):187-91. No abstract available.

    PMID: 4367644BACKGROUND
  • Wurtman RJ, Zhdanova I. Improvement of sleep quality by melatonin. Lancet. 1995 Dec 2;346(8988):1491. doi: 10.1016/s0140-6736(95)92509-0. No abstract available.

    PMID: 7491013BACKGROUND
  • Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. 2005 Feb;9(1):41-50. doi: 10.1016/j.smrv.2004.06.004.

    PMID: 15649737BACKGROUND
  • Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;(2):CD001520. doi: 10.1002/14651858.CD001520.

    PMID: 12076414BACKGROUND
  • Acil M, Basgul E, Celiker V, Karagoz AH, Demir B, Aypar U. Perioperative effects of melatonin and midazolam premedication on sedation, orientation, anxiety scores and psychomotor performance. Eur J Anaesthesiol. 2004 Jul;21(7):553-7. doi: 10.1017/s0265021504007094.

    PMID: 15318468BACKGROUND
  • Naguib M, Samarkandi AH. The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study. Anesth Analg. 2000 Aug;91(2):473-9. doi: 10.1097/00000539-200008000-00046.

    PMID: 10910871BACKGROUND
  • Caumo W, Torres F, Moreira NL Jr, Auzani JA, Monteiro CA, Londero G, Ribeiro DF, Hidalgo MP. The clinical impact of preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy. Anesth Analg. 2007 Nov;105(5):1263-71, table of contents. doi: 10.1213/01.ane.0000282834.78456.90.

    PMID: 17959953BACKGROUND
  • Ismail SA, Mowafi HA. Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia. Anesth Analg. 2009 Apr;108(4):1146-51. doi: 10.1213/ane.0b013e3181907ebe.

    PMID: 19299777BACKGROUND
  • Moerman N, van Dam FS, Muller MJ, Oosting H. The Amsterdam Preoperative Anxiety and Information Scale (APAIS). Anesth Analg. 1996 Mar;82(3):445-51. doi: 10.1097/00000539-199603000-00002.

    PMID: 8623940BACKGROUND
  • Melatonin Monograph. http://www.naturaldatabase.com/(S(nqojvt553k2ihb45ojhbdwu1))/nd/Search.aspx?cs=CPCE&s=ND&pt=100&id=940&ds=&name=MELATONIN&searchid=17337409. Accessed 2/3/15.

    BACKGROUND
  • Ahmad RA, Samarkandi A, Al-Mansouri SM, Obeidan SA. Sedation characteristics of melatonin and midazolam for premedication of adult patients undergoing cataract surgery under local anesthesia. Saudi Journal of Anesthesia 2007;1(1):6.

    BACKGROUND
  • Bajaj P. Melatonin for anxiolysis in children. Indian J Anaesth 2009;53:504-5.

    BACKGROUND
  • Kucukakin, B. Modification of surgical stress response by perioperative melatonin administration. PhD Thesis for Department of Surgical Gastroenterology, University of Copenhagen,

    BACKGROUND
  • Kurdi MS, Patel T. The role of melatonin in anaesthesia and critical care. Indian J Anaesth. 2013 Mar;57(2):137-44. doi: 10.4103/0019-5049.111837.

    PMID: 23825812BACKGROUND
  • Samarkandi A, Naguib M, Riad W, Thalaj A, Alotibi W, Aldammas F, Albassam A. Melatonin vs. midazolam premedication in children: a double-blind, placebo-controlled study. Eur J Anaesthesiol. 2005 Mar;22(3):189-96. doi: 10.1017/s0265021505000335.

    PMID: 15852991BACKGROUND
  • Yousaf F, Seet E, Venkatraghavan L, Abrishami A, Chung F. Efficacy and safety of melatonin as an anxiolytic and analgesic in the perioperative period: a qualitative systematic review of randomized trials. Anesthesiology. 2010 Oct;113(4):968-76. doi: 10.1097/ALN.0b013e3181e7d626.

    PMID: 20823763BACKGROUND
  • Andersen LP, Rosenberg J, Gogenur I. Perioperative melatonin: not ready for prime time. Br J Anaesth. 2014 Jan;112(1):7-8. doi: 10.1093/bja/aet332. No abstract available.

    PMID: 24318695BACKGROUND
  • Capuzzo M, Zanardi B, Schiffino E, Buccoliero C, Gragnaniello D, Bianchi S, Alvisi R. Melatonin does not reduce anxiety more than placebo in the elderly undergoing surgery. Anesth Analg. 2006 Jul;103(1):121-3, table of contents. doi: 10.1213/01.ane.0000222476.62547.ed.

    PMID: 16790638BACKGROUND
  • Pokharel K, Tripathi M, Gupta PK, Bhattarai B, Khatiwada S, Subedi A. Premedication with oral alprazolam and melatonin combination: a comparison with either alone--a randomized controlled factorial trial. Biomed Res Int. 2014;2014:356964. doi: 10.1155/2014/356964. Epub 2014 Jan 12.

    PMID: 24527443BACKGROUND
  • Kennedy DJ, Schneider B, Casey E, Rittenberg J, Conrad B, Smuck M, Plastaras CT. Vasovagal rates in flouroscopically guided interventional procedures: a study of over 8,000 injections. Pain Med. 2013 Dec;14(12):1854-9. doi: 10.1111/pme.12241. Epub 2013 Oct 4.

    PMID: 24118835BACKGROUND
  • Madsen BK, Zetner D, Moller AM, Rosenberg J. Melatonin for preoperative and postoperative anxiety in adults. Cochrane Database Syst Rev. 2020 Dec 8;12(12):CD009861. doi: 10.1002/14651858.CD009861.pub3.

MeSH Terms

Conditions

Anxiety Disorders

Interventions

MelatoninSugars

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

TryptaminesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone AntagonistsCarbohydrates

Study Officials

  • Rick Fisher, DO

    United States Naval Medical Center, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
LCDR, MD

Study Record Dates

First Submitted

April 6, 2015

First Posted

April 14, 2015

Study Start

July 1, 2016

Primary Completion

May 1, 2022

Study Completion

May 1, 2022

Last Updated

May 14, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations